Pressure BioSciences, Inc. (PBIO) – Pressure First, Profits Next
As technology advances leaps and bounds, one thing becomes blazingly clear; the general public, including the average investor, is often unable to fully understand just what the technology "does". This isn't just an isolated incident comprised of a group of below average intelligence consumer/investors, but instead is a widespread problem, confounding even the very analysts that are researching the companies. Nowhere is this situation more evident than in the medical technology field. The advances in genomics, proteomics, drug discovery & development, process purification, pathogen inactivation, immunodiagnostics, DNA sequencing, and all facets of microbiology have been fantastic to say the very…
